Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 4, 2024. (Total: 234082Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 11 (of 11 Records)

Query Trace: Colorectal Neoplasms and EREG[original query]
Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Oct 27 (30): 5068-74.
Jacobs Bart, De Roock Wendy, Piessevaux Hubert, Van Oirbeek Robin, Biesmans Bart, De Schutter Jef, Fieuws Steffen, Vandesompele Jo, Peeters Marc, Van Laethem Jean-Luc, Humblet Yves, Pénault-Llorca Frederique, De Hertogh Gert, Laurent-Puig Pierre, Van Cutsem Eric, Tejpar Sabi
Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in = 2 line cetuximab-based therapy of colorectal cancer patients.
PloS one 2011 6 (1): e15980.
Saridaki Zacharenia, Tzardi Maria, Papadaki Chara, Sfakianaki Maria, Pega Fraga, Kalikaki Aristea, Tsakalaki Eleftheria, Trypaki Maria, Messaritakis Ippokratis, Stathopoulos Efstathios, Mavroudis Dimitris, Georgoulias Vassilis, Souglakos Jo
Intergenic polymorphisms in the amphiregulin gene region as biomarkers in metastatic colorectal cancer patients treated with anti-EGFR plus irinotecan.
The pharmacogenomics journal 2014 Jun 14 (3): 256-62.
Sebio A, Páez D, Salazar J, Berenguer-Llergo A, Paré-Brunet L, Lasa A, Del Río E, Tobeña M, Martín-Richard M, Baiget M, Barnadas
Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.
BMC cancer 2013 Feb 13 (1): 1.
Pentheroudakis G, Kotoula V, De Roock W, Kouvatseas G, Papakostas P, Makatsoris T, Papamichael D, Xanthakis I, Sgouros J, Televantou D, Kafiri G, Tsamandas AC, Razis E, Galani E, Bafaloukos D, Efstratiou I, Bompolaki I, Pectasides D, Pavlidis N, Tejpar S, Fountzilas G
Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy.
Molecular diagnosis & therapy 2015 Sep .
Llovet Patricia, Sastre Javier, Ortega Julián Sanz, Bando Inmaculada, Ferrer Milagros, García-Alfonso Pilar, Donnay Olga, Carrato Alfredo, Jiménez Ana, Aranda Enrique, León Ana, Grávalos Cristina, Cámara Juan Carlos, Feliú Jaime, Sanchíz Bárbara, Caldés Trinidad, Díaz-Rubio Eduar
Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer.
British journal of cancer 2016 Jun 114 (12): 1352-1361.
Lee Michael S, McGuffey Elizabeth J, Morris Jeffrey S, Manyam Ganiraju, Baladandayuthapani Veerabahdran, Wei Wei, Morris Van K, Overman Michael J, Maru Dipen M, Jiang Zhi-Qin, Hamilton Stanley R, Kopetz Sco
Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer.
Cancer biology & therapy 2016 Apr 0.
Sunakawa Yu, Yang Dongyun, Moran Miriana, Astrow Stephanie H, Tsuji Akihito, Stephens Craig, Zhang Wu, Cao Shu, Takahashi Takehiro, Denda Tadamichi, Shimada Ken, Kochi Mitsugu, Nakamura Masato, Kotaka Masahito, Segawa Yoshihiko, Masuishi Toshiki, Takeuchi Masahiro, Fujii Masashi, Nakajima Toshifusa, Ichikawa Wataru, Lenz Heinz-Jos
Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer.
JAMA oncology 2017 Oct .
Seligmann Jenny F, Hatch Ace J, Richman Susan D, Elliott Faye, Jacobs Bart, Brown Sarah, Hurwitz Herbert, Barrett Jennifer H, Quirke Philip, Nixon Andrew B, Seymour Matthew
Amphiregulin Expression Is a Predictive Biomarker for EGFR Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials.
Clinical cancer research : an official journal of the American Association for Cancer Research 2020 9 26 (24): 6559-6567.
Stahler Arndt, Stintzing Sebastian, Modest Dominik P, Ricard Ingrid, Giessen-Jung Clemens, Kapaun Christine, Ivanova Boryana, Kaiser Florian, Fischer von Weikersthal Ludwig, Moosmann Nicolas, Schalhorn Andreas, Stauch Martina, Kiani Alexander, Held Swantje, Decker Thomas, Moehler Markus, Neumann Jens, Kirchner Thomas, Jung Andreas, Heinemann Volk
Artificial Intelligence-Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2021 4 27 (12): 3422-3431.
Williams Christopher J M, Seligmann Jenny F, Elliott Faye, Shires Michael, Richman Susan D, Brown Sarah, Zhang Liping, Singh Shalini, Pugh Judith, Xu Xiao-Meng, Muranyi Andrea, Guetter Christoph, Lorsakul Auranuch, Kurkure Uday, Zhao Zuo, Martin Jim, Wang Xingwei, Nguyen Kien, Liu Wen-Wei, Yan Dongyao, West Nicholas P, Barrett Jennifer H, Barnes Michael, Bai Isaac, Seymour Matthew T, Quirke Philip, Shanmugam Kandav
Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
BMC cancer 2023 11 23 (1): 1117.
Xiaona Lu, Yuyao Li, Yue Li, Xuemei Zhang, Jia Shi, Hai Feng, Zhuo Yu, Yueqiu G
TOP